PFIZER INC (1PFE.MI) Stock Fundamental Analysis
Europe - BIT:1PFE - US7170811035 - Common Stock
20.235 EUR
-0.3 (-1.46%)
Taking everything into account, 1PFE scores 5 out of 10 in our fundamental rating. 1PFE was compared to 50 industry peers in the Pharmaceuticals industry. 1PFE has a medium profitability rating, but doesn't score so well on its financial health evaluation. 1PFE may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
In the past year 1PFE was profitable.
1PFE had a positive operating cash flow in the past year.
1PFE had positive earnings in each of the past 5 years.
Each year in the past 5 years 1PFE had a positive operating cash flow.
1.2 Ratios
1PFE's Return On Assets of 5.22% is in line compared to the rest of the industry. 1PFE outperforms 52.00% of its industry peers.
With a Return On Equity value of 12.12%, 1PFE perfoms like the industry average, outperforming 56.00% of the companies in the same industry.
1PFE's Return On Invested Capital of 8.11% is in line compared to the rest of the industry. 1PFE outperforms 50.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1PFE is below the industry average of 15.33%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.22% | ||
| ROE | 12.12% | ||
| ROIC | 8.11% |
ROA(3y)6.87%
ROA(5y)7.73%
ROE(3y)14.76%
ROE(5y)17.45%
ROIC(3y)10.72%
ROIC(5y)10.58%
1.3 Margins
1PFE has a Profit Margin of 16.84%. This is in the better half of the industry: 1PFE outperforms 70.00% of its industry peers.
1PFE's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 28.52%, 1PFE is doing good in the industry, outperforming 78.00% of the companies in the same industry.
In the last couple of years the Operating Margin of 1PFE has grown nicely.
With a decent Gross Margin value of 73.96%, 1PFE is doing good in the industry, outperforming 72.00% of the companies in the same industry.
1PFE's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.52% | ||
| PM (TTM) | 16.84% | ||
| GM | 73.96% |
OM growth 3Y-8.1%
OM growth 5Y3.31%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.09%
GM growth 5Y-1.57%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1PFE is still creating some value.
1PFE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1PFE has more shares outstanding
The debt/assets ratio for 1PFE has been reduced compared to a year ago.
2.2 Solvency
1PFE has an Altman-Z score of 2.12. This is not the best score and indicates that 1PFE is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.12, 1PFE is in line with its industry, outperforming 42.00% of the companies in the same industry.
1PFE has a debt to FCF ratio of 4.97. This is a neutral value as 1PFE would need 4.97 years to pay back of all of its debts.
1PFE has a Debt to FCF ratio of 4.97. This is comparable to the rest of the industry: 1PFE outperforms 54.00% of its industry peers.
1PFE has a Debt/Equity ratio of 0.65. This is a neutral value indicating 1PFE is somewhat dependend on debt financing.
1PFE has a Debt to Equity ratio of 0.65. This is comparable to the rest of the industry: 1PFE outperforms 50.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 4.97 | ||
| Altman-Z | 2.12 |
ROIC/WACC0.89
WACC9.09%
2.3 Liquidity
1PFE has a Current Ratio of 1.16. This is a normal value and indicates that 1PFE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.16, 1PFE is doing worse than 66.00% of the companies in the same industry.
1PFE has a Quick Ratio of 1.16. This is a bad value and indicates that 1PFE is not financially healthy enough and could expect problems in meeting its short term obligations.
1PFE's Quick ratio of 0.85 is in line compared to the rest of the industry. 1PFE outperforms 42.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.85 |
3. Growth
3.1 Past
1PFE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 151.11%, which is quite impressive.
Measured over the past 5 years, 1PFE shows a small growth in Earnings Per Share. The EPS has been growing by 1.06% on average per year.
1PFE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.54%.
The Revenue has been growing by 9.10% on average over the past years. This is quite good.
EPS 1Y (TTM)151.11%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%30%
Revenue 1Y (TTM)13.54%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%10.31%
3.2 Future
The Earnings Per Share is expected to decrease by -4.48% on average over the next years.
Based on estimates for the next years, 1PFE will show a decrease in Revenue. The Revenue will decrease by -2.85% on average per year.
EPS Next Y0.66%
EPS Next 2Y1.57%
EPS Next 3Y0.49%
EPS Next 5Y-4.48%
Revenue Next Year0.25%
Revenue Next 2Y-0.23%
Revenue Next 3Y-0.84%
Revenue Next 5Y-2.85%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 6.98, which indicates a rather cheap valuation of 1PFE.
1PFE's Price/Earnings ratio is rather cheap when compared to the industry. 1PFE is cheaper than 92.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.32. 1PFE is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 7.36, the valuation of 1PFE can be described as very cheap.
90.00% of the companies in the same industry are more expensive than 1PFE, based on the Price/Forward Earnings ratio.
1PFE is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.89, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.98 | ||
| Fwd PE | 7.36 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1PFE indicates a rather cheap valuation: 1PFE is cheaper than 88.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, 1PFE is valued cheaply inside the industry as 86.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.8 | ||
| EV/EBITDA | 6.85 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)10.59
PEG (5Y)6.57
EPS Next 2Y1.57%
EPS Next 3Y0.49%
5. Dividend
5.1 Amount
1PFE has a Yearly Dividend Yield of 7.14%, which is a nice return.
Compared to an average industry Dividend Yield of 3.10, 1PFE pays a better dividend. On top of this 1PFE pays more dividend than 98.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, 1PFE pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.14% |
5.2 History
The dividend of 1PFE has a limited annual growth rate of 3.30%.
Dividend Growth(5Y)3.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1PFE pays out 89.68% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of 1PFE has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP89.68%
EPS Next 2Y1.57%
EPS Next 3Y0.49%
BIT:1PFE (9/26/2025, 7:00:00 PM)
20.235
-0.3 (-1.46%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners67.15%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap115.05B
Analysts70.67
Price Target25.05 (23.8%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.14% |
Yearly Dividend1.44
Dividend Growth(5Y)3.3%
DP89.68%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.18%
Min EPS beat(2)32.91%
Max EPS beat(2)37.45%
EPS beat(4)4
Avg EPS beat(4)43.14%
Min EPS beat(4)32.52%
Max EPS beat(4)69.69%
EPS beat(8)8
Avg EPS beat(8)56.64%
EPS beat(12)12
Avg EPS beat(12)44.11%
EPS beat(16)16
Avg EPS beat(16)37.53%
Revenue beat(2)1
Avg Revenue beat(2)2.3%
Min Revenue beat(2)-2.36%
Max Revenue beat(2)6.96%
Revenue beat(4)3
Avg Revenue beat(4)5.79%
Min Revenue beat(4)-2.36%
Max Revenue beat(4)17.22%
Revenue beat(8)5
Avg Revenue beat(8)3.23%
Revenue beat(12)8
Avg Revenue beat(12)3.35%
Revenue beat(16)11
Avg Revenue beat(16)3.45%
PT rev (1m)-2.22%
PT rev (3m)-1.33%
EPS NQ rev (1m)2.76%
EPS NQ rev (3m)-15.73%
EPS NY rev (1m)0.4%
EPS NY rev (3m)3.1%
Revenue NQ rev (1m)0.21%
Revenue NQ rev (3m)0.2%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)1.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.98 | ||
| Fwd PE | 7.36 | ||
| P/S | 2.1 | ||
| P/FCF | 10.8 | ||
| P/OCF | 8.84 | ||
| P/B | 1.51 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.85 |
EPS(TTM)2.9
EY14.33%
EPS(NY)2.75
Fwd EY13.58%
FCF(TTM)1.87
FCFY9.26%
OCF(TTM)2.29
OCFY11.31%
SpS9.62
BVpS13.37
TBVpS-4.97
PEG (NY)10.59
PEG (5Y)6.57
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.22% | ||
| ROE | 12.12% | ||
| ROCE | 10.81% | ||
| ROIC | 8.11% | ||
| ROICexc | 8.8% | ||
| ROICexgc | 40.79% | ||
| OM | 28.52% | ||
| PM (TTM) | 16.84% | ||
| GM | 73.96% | ||
| FCFM | 19.48% |
ROA(3y)6.87%
ROA(5y)7.73%
ROE(3y)14.76%
ROE(5y)17.45%
ROIC(3y)10.72%
ROIC(5y)10.58%
ROICexc(3y)12.29%
ROICexc(5y)12.49%
ROICexgc(3y)49.08%
ROICexgc(5y)45.53%
ROCE(3y)14.48%
ROCE(5y)14.24%
ROICexcg growth 3Y-10.89%
ROICexcg growth 5Y27.11%
ROICexc growth 3Y-24.53%
ROICexc growth 5Y9.97%
OM growth 3Y-8.1%
OM growth 5Y3.31%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.09%
GM growth 5Y-1.57%
F-Score7
Asset Turnover0.31
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 4.97 | ||
| Debt/EBITDA | 2.3 | ||
| Cap/Depr | 40.51% | ||
| Cap/Sales | 4.31% | ||
| Interest Coverage | 5.77 | ||
| Cash Conversion | 60.76% | ||
| Profit Quality | 115.66% | ||
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.85 | ||
| Altman-Z | 2.12 |
F-Score7
WACC9.09%
ROIC/WACC0.89
Cap/Depr(3y)55.83%
Cap/Depr(5y)55.63%
Cap/Sales(3y)4.78%
Cap/Sales(5y)4.87%
Profit Quality(3y)143.88%
Profit Quality(5y)138.86%
High Growth Momentum
Growth
EPS 1Y (TTM)151.11%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%30%
EPS Next Y0.66%
EPS Next 2Y1.57%
EPS Next 3Y0.49%
EPS Next 5Y-4.48%
Revenue 1Y (TTM)13.54%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%10.31%
Revenue Next Year0.25%
Revenue Next 2Y-0.23%
Revenue Next 3Y-0.84%
Revenue Next 5Y-2.85%
EBIT growth 1Y65.39%
EBIT growth 3Y-15.3%
EBIT growth 5Y12.71%
EBIT Next Year16.68%
EBIT Next 3Y5.82%
EBIT Next 5Y3.57%
FCF growth 1Y16.62%
FCF growth 3Y-30.95%
FCF growth 5Y-0.32%
OCF growth 1Y4.31%
OCF growth 3Y-26.87%
OCF growth 5Y0.25%